Shai Novik
Executive ChairmanMr. Shai Novik, MBA is the Executive Chairman of Enlivex Therapeutics Ltd. since 2014. Mr. Novik has been the President of OPKO Biologics since May 2007. Mr. Novik is a Co-Founder of GlassesOff (now, InnoVision Labs, Inc.) and previously served as Chief Operating Officer and Head of Strategic Planning of THCG, a technology and life sciences investment company. He served as the Managing Director of A.S. Novik from 2003 to 2005 and of A-Online Capital from 2000 to 2002. He served as the Chief Operating Officer of THCG, Inc. from November 1, 1999 to October 8, 2000. He served as Head of Strategic Planning of THCG Inc. He founded PROLOR Biotech, Inc. (now, OPKO Biologics) in 2005 and served as its President until 2013. from 1998 to 2000. He served as Chief Operating Officer of RogersCasey, an investment advisory company from 1994 to 1998. He co-founded Stentomics Inc. Mr. Novik is the co-founder and a board member of Cortex Therapeutics. He served for years in the Israeli Defense Forces. He has been the Chairman of InnoVision Labs, Inc. since July 2013. Mr. Novik serves as the Chairman of Autovative Products, Inc. and Stentomics Inc. He has been a Director of OPKO Biologics since May 2007. He serves as a Director of Eyekon Inc., Ucansi Inc. and Odysseus Ventures Ltd. He served as a Director of Cazador Acquisition Corp. Ltd. since August 2010. He received his M.B.A, with Distinction, from the Cornell University.
Positions
- Company NameEnlivex Ltd.Stock CodeENLVPositionExecutive ChairmanColleagues
- OHOren HershkovitzChief Executive Officer
- DMDror MevorachFounder & Scientific Advisor
- SSShachar ShlosbergerChief Financial Officer
- VAVeronique Amor-BaroukhChief Operating Officer
- RJRoger James PomerantzIndependent Vice Chairman of the Board
- AHAbraham HavronIndependent Director
- GHGili HartIndependent Director
- MMMitchell M. LevyClinical Advisor
